Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Leukemia and CD109[original query] |
---|
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Sep 30 (25): 3109-18. Mendler Jason H, Maharry Kati, Radmacher Michael D, Mrózek Krzysztof, Becker Heiko, Metzeler Klaus H, Schwind Sebastian, Whitman Susan P, Khalife Jihane, Kohlschmidt Jessica, Nicolet Deedra, Powell Bayard L, Carter Thomas H, Wetzler Meir, Moore Joseph O, Kolitz Jonathan E, Baer Maria R, Carroll Andrew J, Larson Richard A, Caligiuri Michael A, Marcucci Guido, Bloomfield Clara |
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia. Scientific reports 2018 Jul 8 (1): 11293. Hornung Roman, Jurinovic Vindi, Batcha Aarif M N, Bamopoulos Stefanos A, Rothenberg-Thurley Maja, Amler Susanne, Sauerland Maria Cristina, Berdel Wolfgang E, Wörmann Bernhard J, Bohlander Stefan K, Braess Jan, Hiddemann Wolfgang, Lehmann Sören, Mareschal Sylvain, Spiekermann Karsten, Metzeler Klaus H, Herold Tobias, Boulesteix Anne-Lau |
A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study. Blood advances 2019 4 3 (8): 1330-1346. Wagner Sarah, Vadakekolathu Jayakumar, Tasian Sarah K, Altmann Heidi, Bornhäuser Martin, Pockley A Graham, Ball Graham R, Rutella Serg |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: